Dan Renick, Co-President and CCO, Precision for Medicine

Dan Renick, RPh, is Co-President and Chief Commercial Officer of Precision for Medicine and President of Precision for Value. Previously, he was President of Hobart Group Holdings for 6 years prior to its acquisition by Precision for Medicine in 2013. During his more than 20 years within the healthcare industry, Dan has accumulated a wealth of information on a wide range of industry stakeholders through a combination of direct experience, context, and insightful interpretation. Dan has worked in several key areas, including managed care, pharmaceutical managed markets, pharmacy provider operations, and market access strategic consulting.

Dan was formerly the Director of Corporate Pharmacy Management at Humana Inc. In this role, he was responsible for pharmacy programs and trade relations, including oversight of contracting with both pharmaceutical companies and pharmacy provider organizations. In addition, Dan served as the National Director of Pharmacy Networks where he worked with a variety of pharmacy channel stakeholders to improve access and quality in a cost-efficient manner.

Prior to joining Humana, Dan served as a Corporate Account Executive in the managed markets division of Merck & Co., Inc. During his tenure at Merck, Dan worked with large employers, business coalitions, and benefits consultants in support of rational and evidence-based benefit design decisions. In addition, he worked with various other managed markets segments with an emphasis on the senior care market.

Dan received his pharmacy degree from the University of Kentucky and his bachelor of science degree in chemistry and biology from Western Kentucky University.

Areas of Expertise

  • Managed care, pharmaceutical managed markets, pharmacy provider operations, and market access strategic consulting
  • Managed markets segments, including the senior care marketplace and employer groups


Back to Transforming Healthcare Conference Speaker List